Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “New York”

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting
NCT06841354Phase 3Updated Sep 3, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +30 more
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)Recruiting
NCT06717347Phase 3Updated Sep 3, 2026
Sponsor: Merck Sharp & Dohme LLC
Diffuse Large B-Cell Lymphoma
United States, Argentina, Australia, Belgium, Brazil +30 more
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Recruiting
NCT06393374Phase 3Updated Sep 3, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple-Negative Breast Cancer
United States, Argentina, Australia, Austria, Belgium +26 more
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)Recruiting
NCT07630974Phase 1, Phase 2Updated Sep 3, 2026
Sponsor: Merck Sharp & Dohme LLC
Malignant Neoplasm
United States, Belgium, Denmark, France, Israel +3 more
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With BronchiectasisRecruiting
NCT06872892Phase 3Updated Sep 3, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Argentina, Australia, Austria, Belgium +40 more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting
NCT06632457Phase 3Updated Sep 3, 2026
Sponsor: Boehringer Ingelheim
Metabolic Dysfunction Associated Steatohepatitis
United States, Argentina, Australia, Austria, Belgium +31 more
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur TrialRecruiting
NCT05673148Phase 2Updated Sep 3, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Metastatic Colorectal Adenocarcinoma · Stage IV Colorectal Cancer AJCC v8 · Oligometastatic Colorectal Carcinoma
United States, Canada
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaRecruiting
NCT05677490Phase 3Updated Sep 3, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma · Clinical Stage III Esophageal Adenocarcinoma AJCC v8
United States, Puerto Rico
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisRecruiting
NCT07697456Phase 2Updated Sep 3, 2026
Sponsor: AbbVie
Crohn's Disease · Ulcerative Colitis
United States, Taiwan
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)Active Not Recruiting
NCT05763407NAUpdated Sep 2, 2026
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)
Heart Failure
United States
Treatment With Endovascular Intervention for STroke Patients With Existing DisabilityRecruiting
NCT05911568N/AUpdated Sep 2, 2026
Sponsor: University of Cincinnati
Stroke · Stroke, Acute · Stroke, Ischemic
United States
Breast Cancer WEight Loss Study (BWEL Study)Active Not Recruiting
NCT02750826Phase 3Updated Sep 2, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Breast Ductal Carcinoma In Situ · Invasive Breast Carcinoma · Stage II Breast Cancer AJCC v6 and v7 · Stage IIB Breast Cancer AJCC v6 and v7
United States, Canada, Guam, Puerto Rico
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Recruiting
NCT06072612Phase 3Updated Sep 2, 2026
Sponsor: BriaCell Therapeutics Corporation
Breast Cancer · Metastatic Breast Cancer · Breast Neoplasm · Breast Cancer Metastatic
United States
remedē System Therapy StudyActive Not Recruiting
NCT03884660N/AUpdated Sep 2, 2026
Sponsor: Respicardia, Inc.
Central Sleep Apnea
United States, Netherlands
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)Recruiting
NCT06953960Phase 1, Phase 2Updated Sep 2, 2026
Sponsor: AbbVie
Multiple Myeloma
United States, Australia, Belgium, France, Germany +7 more
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)Recruiting
NCT04374305Phase 2Updated Sep 2, 2026
Sponsor: Scott R. Plotkin, MD, PhD
Neurofibromatosis Type 2 · Vestibular Schwannoma · Non-vestibular Schwannoma · Meningioma
United States
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After TreatmentRecruiting
NCT07293247Phase 2Updated Sep 2, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Lung Non-Small Cell Carcinoma
United States
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentRecruiting
NCT07036523Phase 2Updated Sep 2, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
United States, Australia, Belgium, Canada, Germany +5 more
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial CarcinomaCompleted
NCT03502785Phase 1, Phase 2Updated Sep 2, 2026
Sponsor: Inovio Pharmaceuticals
Urothelial Carcinoma
United States
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaActive Not Recruiting
NCT06468228Phase 3Updated Sep 2, 2026
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +39 more
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerRecruiting
NCT07215910Phase 3Updated Sep 2, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Astrocytoma, IDH-Mutant, Grade 3
United States
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell LymphomaRecruiting
NCT05976763Phase 3Updated Sep 2, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Mantle Cell Lymphoma
United States
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialActive Not Recruiting
NCT05247905Phase 2Updated Sep 2, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Metastatic Pancreatic Neuroendocrine Tumor · Unresectable Pancreatic Neuroendocrine Carcinoma
United States
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use DisorderRecruiting
NCT07644052Phase 3Updated Sep 2, 2026
Sponsor: PleoPharma, Inc.
Cannabis Withdrawal
United States
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialSuspended
NCT06671912Phase 3Updated Sep 2, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Anatomic Stage 0 Breast Cancer AJCC v8 · Anatomic Stage 1 Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Estrogen Receptor-Positive Breast Carcinoma
United States, Puerto Rico

Previous page Next page